Since 2015 we have been proud to partner and support clients who are at the forefront of creating groundbreaking new treatments and therapies.
We carefully select and recruit the highest calibre of personnel. Every member of
our team is an expert in their field and passionate about access for Rare Diseases.
As global experts in access for orphan drug, cell and gene therapy,
we truly understand the complexity and challenges of the market
access environment. P4A solutions are designed to be bespoke
to your situation, location and needs. One size does not fit all.
Our 2-minute promotional video will give you a thorough overview
into P4A and our tailored, meticulous and innovative approach.
We are an award-winning global consultancy and recognised
for excellence in access for orphan drugs & Cell and Gene Therapies.
London – 18.06.2025 – Partners4Access (P4A), a global expert in market access for orphan drugs and advanced therapies, is proud to announce the launch of
Amsterdam – 12.06.2025 – Partners4Access (P4A), a global consultancy specializing in access strategy for orphan and rare diseases, proudly announces that Associate Consultant, Johann Sanseau
Written by Pina Haberl, Senior Director & Chief People Officer Disclaimer: (Last updated: May 22, 2025 | Subject to final G-BA plenary resolution in July
AI Powered simulator that predicts probable PICO selections
